1,25-DIHYDROXYVITAMIN D-3 - A NOVEL AGENT FOR ENHANCING WOUND-HEALING

被引:42
|
作者
TIAN, XQ
CHEN, TC
HOLICK, MF
机构
[1] BOSTON UNIV, MED CTR, DEPT MED, VITAMIN D SKIN & BONE RES LAB, BOSTON, MA 02115 USA
[2] BOSTON UNIV, MED CTR, DEPT MED, ENDOCRINE SECT, BOSTON, MA 02115 USA
关键词
1,25-DIHYDROXYVITAMIN D-3; WOUND HEALING; VITAMIN-D;
D O I
10.1002/jcb.240590107
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
1,25-Dihydroxyvitamin D-3 (1,25(OH)(2)D-3), has diverse effects in a variety of tissues and cell types, including skin. Since 1,25(OH)(2)D-3 affects both fibroblast and keratinocytes, we evalauated the effect of 1,25(OH)(2)D-3 on wound healing. We investigated the effect of the topically applied 1,25(OH)(2)D-3 or vehicle on the healing of cutaneous wounds in rats in a blinded manner. Wound areas were measured by planimetry technique. Healing was expressed as the percentage of the original wound area that was healed. 1,25(OH)(2)D-3 at concentrations between 5 and 50 ng/day caused a dose-dependent acceleration of healing. Time course and specificity studies indicated that 1,25(OH)(2)D-3 specifically promoted healing between 1-5 days after wounding as compared with vitamin D (0.5 mu g/day), which showed no significant improvement over control. Our results suggest that 1,25(OH)(2)D-3 and its analogues may be anew class of compounds that could be developed to enhance wound healing. (C) 1995 Wiley-Liss, Inc.
引用
收藏
页码:53 / 56
页数:4
相关论文
共 50 条
  • [21] Regulation of apoptosis in adipocytes and breast cancer cells by 1,25-dihydroxyvitamin D-3 : a link between obesity and breast cancer
    Sergeev, Igor N.
    HORMONE MOLECULAR BIOLOGY AND CLINICAL INVESTIGATION, 2013, 14 (03) : 99 - 106
  • [22] Vitamin D and 1,25-dihydroxyvitamin D3 as modulators in the immune system
    Mathieu, C
    van Etten, E
    Decallonne, B
    Guilietti, A
    Gysemans, C
    Bouillon, R
    Overbergh, L
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2004, 89-90 (1-5) : 449 - 452
  • [23] DISTRIBUTION OF 1,25-DIHYDROXYVITAMIN D-3[22-OXA] IN-VIVO RECEPTOR-BINDING IN ADULT AND DEVELOPING SKIN
    STUMPF, WE
    KOIKE, N
    HAYAKAWA, N
    TOKUDA, K
    NISHIMIYA, K
    HIRATE, J
    OKAZAKI, A
    KUMAKI, K
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 1995, 287 (3-4) : 294 - 303
  • [24] A case of hypercalcemia Indications for 1,25-dihydroxyvitamin D prescription
    Malandain, Damasie
    Roussey, Gwenaelle
    Leloupp, Anne-Gaelle
    Graveline, Nolwenn
    Masson, Damien
    Bach-Ngohou, Kalyane
    ANNALES DE BIOLOGIE CLINIQUE, 2015, 73 (05) : 573 - 580
  • [25] Discovery of novel vitamin D receptor interacting proteins that modulate 1,25-dihydroxyvitamin D3 signaling
    Marshall, Pamela A.
    Hernandez, Zachary
    Kaneko, Ichiro
    Widener, Tim
    Tabacaru, Christa
    Aguayo, Izayadeth
    Jurutka, Peter W.
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2012, 132 (1-2) : 147 - 159
  • [26] INFLUENCE OF TUMOR-DERIVED FIBROBLASTS AND 1,25-DIHYDROXYVITAMIN D-3 ON GROWTH OF BREAST-CANCER CELL-LINES
    LEFEBVRE, MF
    GUILLOT, C
    CREPIN, M
    SAEZ, S
    BREAST CANCER RESEARCH AND TREATMENT, 1995, 33 (03) : 189 - 197
  • [27] Effects of a sustained release formulation of 1,25-dihydroxyvitamin D3-glycosides for milk fever prevention on serum 1,25-dihydroxyvitamin D3, calcium and phosphorus in dairy cows
    Bachmann, Heinrich
    Lanz, Michael
    Kehrle, Susanne
    Bittner, Wolfgang
    Toggenburger, Annick
    Mathis, Georg A.
    Rambeck, Walter
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2017, 173 : 301 - 307
  • [28] Synthesis and Crystal Structure of Anhydrous Analog of 1,25-Dihydroxyvitamin D3
    Pietraszek, Anita
    Malinska, Maura
    Chodynski, Michal
    Martynow, Jacek
    Krupa, Malgorzata
    Maruszak, Wioleta
    Wozniak, Krzysztof
    Kutner, Andrzej
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2013, 102 (11) : 3925 - 3931
  • [29] 1,25-dihydroxyvitamin D-3 and its analogues inhibit acute myelogenous leukemia progenitor proliferation by suppressing interleukin-1 beta production
    Peleg, S
    Qiu, HY
    Reddy, S
    Harris, D
    Van, Q
    Estey, EH
    Talpaz, M
    Estrov, Z
    JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (07) : 1716 - 1724
  • [30] Stimulation of in-vitro angiogenesis by low concentrations of risedronate is mitigated by 1,25-dihydroxyvitamin D3 or 24,25-dihydroxyvitamin D3
    Manuel Quesada-Gomez, Jose
    Santiago-Mora, Raquel
    Navarro-Valverde, Cristina
    Dorado, Gabriel
    Casado-Diaz, Antonio
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2015, 148 : 214 - 218